Structures of langya virus fusion protein ectodomain and immunogenic compositions derived therefrom
US-2024358817-A1 · Oct 31, 2024 · US
Vaccine
US8926985B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8926985-B2 |
| Application number | US-61298809-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 5, 2009 |
| Priority date | Mar 19, 1999 |
| Publication date | Jan 6, 2015 |
| Grant date | Jan 6, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from H. influenzae.
First claim
Opening claim text (preview).
The invention claimed is: 1. A multivalent immunogenic composition comprising isolated capsular polysaccharides of at least four serotypes of Streptococcus pneumoniae , each of said isolated capsular polysaccharides conjugated to an isolated protein D from Haemophilus influenzae that lacks a leader peptide and the N-terminal cysteine and contains a T-helper epitope, wherein the protein D is not lipidated. 2. The immunogenic composition of claim 1 additional…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8926985B2 cover?
- The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from H. influenzae.
- Who is the assignee on this patent?
- Capiau Carine, Deschamps Marguerite, Desmons Pierre Michel, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification A61K39/155. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).